WO2023025045A1 - Luminal stent - Google Patents

Luminal stent Download PDF

Info

Publication number
WO2023025045A1
WO2023025045A1 PCT/CN2022/113477 CN2022113477W WO2023025045A1 WO 2023025045 A1 WO2023025045 A1 WO 2023025045A1 CN 2022113477 W CN2022113477 W CN 2022113477W WO 2023025045 A1 WO2023025045 A1 WO 2023025045A1
Authority
WO
WIPO (PCT)
Prior art keywords
tubular body
wire
binding
wave
stent according
Prior art date
Application number
PCT/CN2022/113477
Other languages
French (fr)
Chinese (zh)
Inventor
唐春炜
Original Assignee
先健科技(深圳)有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 先健科技(深圳)有限公司 filed Critical 先健科技(深圳)有限公司
Publication of WO2023025045A1 publication Critical patent/WO2023025045A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts

Definitions

  • the present application relates to the technical field of interventional medical devices, in particular to a lumen stent.
  • aortic stent grafts In the past ten years, endovascular exclusion of aortic stent grafts has been widely used in thoracic and abdominal aortic aneurysms and arterial dissections. treatment method.
  • the covered stent is sent to the lesion through the corresponding delivery system.
  • the covered stent isolates the blood flow from the lesion, eliminates the influence of blood pressure on the lesion, and achieves the purpose of healing.
  • development marks are usually made at key positions of the stent, and the axial and circumferential directions of the stent-graft are positioned using the development marks.
  • the stent-graft when it is compressed in the delivery sheath, it has compression folds in the circumferential direction and is in an elongated state in the axial direction. If it is positioned by the development mark at this time, there will be large circumferential and axial deviations. Therefore, in the prior art, the stent-graft is constrained radially by binding the wire harness, so that the stent-graft is in a half-release state.
  • the stent-graft When the stent-graft is in a semi-released state, its outer diameter is larger than that when it is loaded in the conveyor, and is smaller than the outer diameter of the stent-graft when it is fully released and anchored in the lumen of the human body. Compared with positioning the position of the stent-graft through the development structure when the stent-graft is loaded in the conveyor, the outer diameter of the stent-graft in the semi-released state is closer to the outer diameter of the fully released state, and positioning through the development structure will also more precise.
  • the present application provides a lumen stent, which includes a tubular body and a semi-release device connected to the tubular body, the semi-release device includes a binding wire and at least two limit rods arranged on the tubular body, the binding The wire has a locking portion, and the at least two limiting rods are limited to the tubular body at intervals along the circumferential direction of the tubular body, and are used for detachable connection with the locking portion, wherein, when the limiting rods When connected with the locking part, the locking part is limited to the limiting rod along the radial direction of the limiting rod and makes the binding wire constrain the tubular main body in a circumferential direction.
  • Fig. 1 is a schematic structural view of a lumen stent of an embodiment
  • Fig. 2 is a schematic diagram of the structure of the endoluminal stent shown in Fig. 1 , when the cooperation between the first limiting rod and the locking part is released to partially release the endoluminal stent;
  • FIG. 3 is a schematic structural view of a lumen stent in another embodiment
  • Fig. 4 is an enlarged schematic view of the local structure at the circle of the lumen stent shown in Fig. 3;
  • Fig. 5 is a schematic structural view of another embodiment of a luminal stent
  • Fig. 6 is a schematic structural view of yet another embodiment of a luminal stent
  • Fig. 7 is a schematic structural view of a lumen stent in another embodiment
  • Fig. 8 is a schematic structural view of a lumen stent in another embodiment
  • Fig. 9 is a schematic structural view of another embodiment of a luminal stent.
  • Fig. 10 is a schematic structural view of another embodiment of a luminal stent
  • Fig. 11 is a schematic structural view of a lumen stent in another embodiment
  • Fig. 12 is a schematic structural view of a lumen stent in another embodiment
  • Fig. 13 is a schematic diagram of the partial structure of the binding channel corresponding to the confinement of the wave-shaped ring in the endoluminal stent of an embodiment.
  • end of the endoluminal stent that is closer to the heart after release is defined as the proximal end, and the end farther from the heart is defined as the distal end.
  • one embodiment of the present application provides a lumen stent, which includes a tubular body 10 and a semi-releasing device 20 connected to the tubular body 10 for constraining the tubular body 10 radially.
  • the half release device 20 includes at least two limiting rods 21 and a binding wire 22 arranged on the tubular body 10 .
  • the binding wire 22 has a locking portion 22a, and at least two limiting rods 21 are limited to the tubular body 10 along the circumferential direction of the tubular body 10 at intervals.
  • each limiting rod 21 is limited to the tubular main body 10, and then cannot move relative to the tubular main body 10 along the circumferential direction of the tubular main body 10, so that the limiting rods 21 are connected to the locking portion 22a
  • the tubular main body 10 can be constrained circumferentially by the binding wire 22, specifically, when the limiting rod 21 is connected to the locking portion 22a, the locking portion 22a is limited to the limiting rod 21 along the radial direction of the limiting rod 21 and
  • the binding wire 22 is made to bind the tubular body 10 circumferentially.
  • the limiting rod 21 and the locking portion 22a are detachably connected, so that when the limiting rod 21 is separated from the locking portion 22a, the binding of the limiting rod 21 to the binding wire by the locking portion 22a can be released. 22 exerts traction on the binding force on the tubular body 10, so that part of the tubular body 10 is released. And because the half release device 20 includes at least two limit rods 21, when releasing different limit rods 21 successively, the restrained position of the tubular body 10 can be released step by step, so as to improve the controllability of the release operation. performance and release positioning accuracy.
  • one of the at least two limit rods 21 can be released first, thereby releasing the restraint of a part of the tubular body 10 by the restraining wire 22 , so that the size of the tubular body 10 is closer to the size anchored in the blood vessel, so that the positioning of the tubular body is more precise.
  • the binding wire 22 is connected with the tubular main body 10, and folded in half to form a first wire bundle 221 and a second wire bundle 222, the folding position of the binding wire 22 forms a locking portion 22a, and at least two limit rods 21 are passed through the first wire bundle 221 and the second wire harness 222.
  • the three limit rods 21 are respectively referred to as “the first limit rod 21'” and “the second limit rod 21'”.
  • the rod 21"" and the “third limiting rod 21"'", the first limiting rod 21', the second limiting rod 21” and the third limiting rod 21”' are spaced apart from each other along the circumferential direction of the tubular body 10
  • the ground is limited to the tubular body 10 .
  • the first limit rod 21', the second limit rod 21" and the third limit rod 21"' are all passed between the first strand bundle 221 and the second strand bundle 222, so as to release the first strand close to the locking part 22a.
  • the part of the tubular main body 10 loses the restraint of the binding line 22 and expands, that is, the part of the tubular main body 10 is released until the locking part 22a is matched with the second stop bar 21" (see Fig. 2 shown), at this time, the binding wire 22 is kept in a relaxed state by the tubular body 10 under the constraint of the second limit rod 21", and at the same time, the tubular body 10 no longer continues to expand under the constraint of the binding line 22, that is, the tubular body 10 is still in a partially circumscribed state.
  • the tubular body 10 After the first limiting rod 21 ′ is separated from the locking portion 22a, a part of the tubular body 10 loses the circumferential restraint of the binding wire 22 and unfolds, so that the unfolded part has good stability.
  • the tubular body 10 will expand to make the locking part 22a cooperate with the third limiting rod 21"'.
  • the binding wire 22 Under the constraint of the third limit rod 21"', the tubular body 10 is kept in a relaxed state. At the same time, the tubular body 10 no longer continues to expand under the constraint of the binding line 22, that is, the tubular body 10 is still partially bound in the circumferential direction. status.
  • the tubular body 10 will be fully unfolded and released.
  • the endoluminal stent of the present invention can meet the requirement of step-by-step release of the tubular body 10, so that the controllability of the release operation is good, and the positioning accuracy can be improved when the tubular body 10 is moved to the position to be implanted.
  • the branch window 105 is provided with a part between the first limit rod 21 ′ and the second limit rod 21 ′′. Since this part can pass through the first limit rod 21 ′ The cooperation with the locking part 22a is released, that is, it is no longer bound by the binding wire 22 and is in a relaxed state, which has good stability. To be exact, after the first limiting rod 21' is separated from the locking part 22a, the second The two limit rods 21" can continue to keep the binding wire 22 in the state of partially circumferentially restraining the tubular body 10, so as to adjust the position of the tubular body 10 and position the branch window 105, thereby improving the positioning accuracy of the branch window 105 .
  • the components that need to be positioned are not limited to the branch window 105, and may also be other components that require high positioning, such as branches or keels, and these components are provided with the tubular body 10 corresponding to the two limit rods 21, you can improve the accuracy of the release position through the aforementioned step-by-step release method.
  • a positioning structure may be used, It is also possible to use the above-mentioned binding wire 22 itself to restrict the limiting rod 21 relative to the tubular body 10 at the connection position of the first strand bundle 221 and the second strand bundle 222 with the tubular body 10 .
  • a locking buckle 104 is fixedly connected to the tubular body 10 , and the locking buckle 104 is used for allowing any one of at least two limiting rods 21 to pass through.
  • the tubular body 10 is fixedly connected with a plurality of locks 104, the number of the locks 104 is equal to the number of the limit rods 21, and the plurality of locks 104 correspondingly limit the limit rods 21 to the tubular body 10 along the circumferential direction of the tubular body 10.
  • Subject 10
  • a plurality of locking buckles 104 are fixedly connected to the tubular body 10 , and at least two limiting rods 21 are respectively movably threaded through the plurality of locking buckles 104 along their own axial directions.
  • one of the at least two limiting rods 21 is bound by the binding line 22 between the binding line 22 and the At the connection position of the tubular body 10 , a plurality of locking buckles 104 correspondingly limit the other limiting rods 21 to the tubular body 10 along the circumferential direction of the tubular body 10 .
  • the number of limit rods 21 is two, which are respectively the first limit rod 21' and the second limit rod 21", and the first limit rod 21'
  • the first limit rod 21' In the direction opposite to the extension direction of the tubular main body 10 along the peripheral side of the tubular main body 10 with the binding line 22 , the connection position of the first strand bundle 221 and the second strand bundle 222 bound by the binding wire 22 to the tubular main body 10 , the locking buckle 104 correspondingly constrains the second limiting rod 21 ′′ on the tubular main body 10 along the circumferential direction of the tubular main body 10 .
  • the binding wire 22 has a fixed part 22b and at least two locking parts 22a, the fixed part 22b is fixedly connected with the tubular main body 10, and at least two limit rods 21 are correspondingly installed in at least two locking part 22a, so that after releasing the cooperation between the corresponding stop rod 21 and the lock part 22a, the binding wire 22 correspondingly releases the local restraint on the tubular main body 10, so that the stop rods 21 at different positions are successively pulled away, which can realize The effect of the stepwise release of the tubular body 10 .
  • these locking portions 22a may be located on the same side or different sides relative to the fixing portion 22b.
  • these locking portions 22a may be located on different sides of the fixing portion 22b at intervals from each other.
  • the binding wire 22 has a fixed portion 22b and a wire loop 22c, the fixed portion 22b is fixedly connected to the tubular body 10, and the end position of the wire loop 22c away from the fixed portion 22b forms a locking portion 22a
  • Two or more limit rods 21 are passed through the wire loop 22c, so that after the limit rod 21 matched with the locking part 22a is pulled out, the tubular main body 10 expands so that the lock part 22a of the wire ring 22c and the Adjacent limit rods 21 are matched, and so on, and the limit rods 21 matched with the locking portion 22a are sequentially pulled out, so that the tubular body 10 can be released step by step, thereby improving the controllability of the release operation and the release accuracy. sex.
  • the binding wire 22 has at least 2 wire loops 22c, and at least 2 wire loops 22c are located at different sides of the fixing part 22b (see FIG. 8 ) or on the same side ( See Figure 9).
  • the tubular body 10 is provided with a binding channel 24 , the central angle corresponding to the binding channel 24 is less than 360°, and the position of the binding channel 24 corresponding to the limit rod 21 is formed with an opening 24 a , and the opening 24 a is connected to the inside of the binding channel 24 .
  • the cavities are connected, the restraint wire 22 passes through the restraint passage 24, and the locking portion 22a is used to connect with the corresponding limit rod 21 at the opening 24a.
  • the structure of the binding channel 24 has many possibilities.
  • the binding channel 24 is formed between the cover 103 and the covering film 102; or, as shown in FIGS. A buckle 223 is formed, and the binding wire 22 passes through the buckle 223 of the limiting ring.
  • the tubular body 10 includes a wave-shaped ring 101 , and the wave-shaped ring 101 is made of materials with good biocompatibility, such as nickel-titanium, stainless steel and other materials.
  • the multi-turn wave-shaped rings 101 are arranged sequentially along the axial direction of the tubular body 10 from the proximal end to the distal end, preferably in parallel and at intervals.
  • the wave-shaped ring 101 includes a plurality of crests 101a, a plurality of troughs 101b, and a plurality of connecting rods 101c respectively connecting adjacent crests 101a and troughs 101b.
  • the wave-shaped ring 101 is a closed cylindrical structure, and the multi-turn wave-shaped rings 101 may have the same or similar wave shapes. It can be understood that this embodiment does not limit the specific structure of the wave-shaped ring 101.
  • the wave-shaped ring The waveform of the shape 101 can be set as required, and the number of waveforms and the height of the waveform in each wave ring 101 can be set as required.
  • the multi-circle corrugated ring 101 is connected with a coating 102, and the coating 102 is made of a polymer material with good biocompatibility, such as PTFE (Poly tetrafluoroethylene, polytetrafluoroethylene), FEP (Fluorinated ethylene propylene, Perfluoroethylene propylene copolymer) and PET (Polyethylene terephthalate, polyethylene terephthalate), etc.
  • PTFE Poly tetrafluoroethylene, polytetrafluoroethylene
  • FEP Fluorinated ethylene propylene, Perfluoroethylene propylene copolymer
  • PET Polyethylene terephthalate, polyethylene terephthalate
  • the wave-shaped ring 101 in the axial section where the wave-shaped ring 101 is located, there are at least two confinement channels 24 arranged at intervals on the tubular body 10 corresponding to the wave-shaped ring 101 .
  • the binding wires 22 in at least two binding channels 24 are respectively used to apply radial binding force to one side and the other side of the neutral coil of the wave-shaped ring 101 .
  • the neutral coil refers to the ring coil formed by sequentially connecting the midpoints of the connecting rods 101c in the wave-shaped ring 101 along the peripheral side of the tubular body 10 .
  • the crests 101a and troughs 101b of the wave-shaped ring 101 are uniformly restrained, thereby avoiding the uneven force on the crests 101a and troughs 101b and causing them to be biased to one side, which in turn will cause the crests 101a or troughs 101b to warp and align with the blood vessels.
  • Wall anchoring or contact friction is relatively large, which affects the adjustment of the axial and circumferential positions of the luminal stent.
  • the wave-shaped ring 101 also includes a first area A1 and a second area A2 that are opposite to each other along its axial direction and surround its circumference.
  • the width D1 of the first area A1 is represented by the peak 101a is the starting point and extends axially toward the trough 101b for 2/5 times the wave height, that is to say, the two sides b1 and b2 defining the width D1 of the first region A1 surround the corresponding peak 101a of the wave-shaped ring 101 respectively. position, and the vertical distance to the peak 101a is 2/5 times the wave height.
  • the width D2 of the second area A2 is 2/5 times the wave height starting from the wave trough 101b and extending axially toward the wave peak 101a, that is to say, the two sides b3 and b4 defining the width D2 of the second area A2 surround
  • the position of the wave-shaped ring 101 corresponds to the trough 101b, and the vertical distance to the trough 101b is 2/5 times the wave height.
  • the wave height refers to the vertical distance from the wave crest 101 a to the wave trough 101 b along the axis direction of the wave-shaped ring 101 .
  • At least one of the at least two confinement channels 24 is located in the first area A1, and at least one of the at least two confinement channels 24 is located in the second area A2. Therefore, the binding wires 22 located in the binding channel 24 respectively constrain the positions corresponding to the first area A1 and the second area A2 of the wave-shaped ring 101, so that the positions of the peaks 101a and the valleys 101b of the wave-shaped ring 101 are restricted.
  • the force is uniform to improve the stability of the tubular body 10 and avoid the crests 101a or troughs 101b from warping.

Abstract

A luminal stent, comprising a tubular main body (10) and a semi-release device (20), which is connected to the tubular body (10). The semi-release device (20) comprises a binding line (22), which is arranged on the tubular body (10), and at least two limiting rods (21), wherein the binding line (22) is provided with locking portions (22a); at least two limiting rods (21) are limited on the tubular main body (10) at an interval in the circumferential direction of the tubular body (10) and are used for being detachably connected to the locking portions (22a); and when the limiting rods (21) are connected to the locking portions (22a), the locking portions (22a) are limited on the limiting rods (21) in the radial direction of the limiting rods (21) and enable the binding line (22) to bind the tubular main body (10) in the circumferential direction.

Description

管腔支架Endoluminal stent 技术领域technical field
本申请涉及介入医疗器械技术领域,尤其涉及一种管腔支架。The present application relates to the technical field of interventional medical devices, in particular to a lumen stent.
背景技术Background technique
近十余年来,主动脉覆膜支架腔内隔绝术已广泛应用于胸、腹主动脉的动脉瘤和动脉夹层等病变,其疗效确切、创伤小、恢复快、并发症少,已成为一线的治疗方法。手术时,在X线透视监视下,通过相应的输送系统将覆膜支架送到病变位置,覆膜支架将血流与病变位置隔绝,消除血压对病变位置的影响,以达到治愈的目的。In the past ten years, endovascular exclusion of aortic stent grafts has been widely used in thoracic and abdominal aortic aneurysms and arterial dissections. treatment method. During the operation, under X-ray fluoroscopy monitoring, the covered stent is sent to the lesion through the corresponding delivery system. The covered stent isolates the blood flow from the lesion, eliminates the influence of blood pressure on the lesion, and achieves the purpose of healing.
为了解决覆膜支架在体内的定位问题,通常会在支架的关键位置做显影标记,利用显影标记对覆膜支架的轴向和周向进行定位。但是,当覆膜支架压缩在输送鞘管内时,其周向具有压缩褶皱,且轴向处于伸长状态,若此时通过显影标记定位,会存在较大的周向和轴向偏差。因此,现有技术中通过束缚线束对覆膜支架进行径向约束,使得覆膜支架处于半释放状态。覆膜支架处于半释放状态时,其外径大于装载于输送器内时的外径,且外径小于覆膜支架完全释放并锚定于人体管腔内的外径。相较于将覆膜支架装载于输送器内状态下通过显影结构定位覆膜支架的位置,覆膜支架处于半释放状态时的外径更接近完全释放时的外径,通过显影结构定位也会更加精准。In order to solve the positioning problem of the stent-graft in the body, development marks are usually made at key positions of the stent, and the axial and circumferential directions of the stent-graft are positioned using the development marks. However, when the stent-graft is compressed in the delivery sheath, it has compression folds in the circumferential direction and is in an elongated state in the axial direction. If it is positioned by the development mark at this time, there will be large circumferential and axial deviations. Therefore, in the prior art, the stent-graft is constrained radially by binding the wire harness, so that the stent-graft is in a half-release state. When the stent-graft is in a semi-released state, its outer diameter is larger than that when it is loaded in the conveyor, and is smaller than the outer diameter of the stent-graft when it is fully released and anchored in the lumen of the human body. Compared with positioning the position of the stent-graft through the development structure when the stent-graft is loaded in the conveyor, the outer diameter of the stent-graft in the semi-released state is closer to the outer diameter of the fully released state, and positioning through the development structure will also more precise.
然而,管腔支架的轴向和周向定位过程中,可控性较差,定位精准度遇到瓶颈,管腔支架展开过程的稳定性亟需改善。However, during the axial and circumferential positioning of the luminal stent, the controllability is poor, the positioning accuracy encounters a bottleneck, and the stability of the luminal stent deployment process needs to be improved urgently.
发明内容Contents of the invention
基于此,有必要提供一种管腔支架。Based on this, it is necessary to provide a lumen stent.
本申请提供一种管腔支架,包括管状主体以及连接在管状主体上的半释放装置,所述半释放装置包括设于所述管状主体上的束缚线以及至少2根限位杆,所述束缚线具有锁定部,所述至少2根限位杆沿所述管状主体的周向彼此间隔地限位于所述管状主体,并用于与所述锁定部可分离连接,其中,当所述限位杆与所述锁定部相连接时,所述锁定部沿所述限位杆的径向限位于所述限位杆并使得所述束缚线对所述管状主体周向束缚。The present application provides a lumen stent, which includes a tubular body and a semi-release device connected to the tubular body, the semi-release device includes a binding wire and at least two limit rods arranged on the tubular body, the binding The wire has a locking portion, and the at least two limiting rods are limited to the tubular body at intervals along the circumferential direction of the tubular body, and are used for detachable connection with the locking portion, wherein, when the limiting rods When connected with the locking part, the locking part is limited to the limiting rod along the radial direction of the limiting rod and makes the binding wire constrain the tubular main body in a circumferential direction.
附图说明Description of drawings
下面将结合附图及实施例对本发明作进一步说明,附图中:The present invention will be further described below in conjunction with accompanying drawing and embodiment, in the accompanying drawing:
图1是一实施例的管腔支架的结构示意图;Fig. 1 is a schematic structural view of a lumen stent of an embodiment;
图2是图1示出的管腔支架,解除第一限位杆与锁定部配合后使得管腔支架局部释放时的结构示意图;Fig. 2 is a schematic diagram of the structure of the endoluminal stent shown in Fig. 1 , when the cooperation between the first limiting rod and the locking part is released to partially release the endoluminal stent;
图3是另一实施例的管腔支架的结构示意图;3 is a schematic structural view of a lumen stent in another embodiment;
图4是图3示出的管腔支架的圈圈处的局部结构放大示意图;Fig. 4 is an enlarged schematic view of the local structure at the circle of the lumen stent shown in Fig. 3;
图5是管腔支架的另一实施方式的结构示意图;Fig. 5 is a schematic structural view of another embodiment of a luminal stent;
图6是管腔支架的再一实施方式的结构示意图;Fig. 6 is a schematic structural view of yet another embodiment of a luminal stent;
图7是再一实施例的管腔支架的结构示意图;Fig. 7 is a schematic structural view of a lumen stent in another embodiment;
图8是又一实施例的管腔支架的结构示意图;Fig. 8 is a schematic structural view of a lumen stent in another embodiment;
图9是管腔支架的又一实施方式的结构示意图;Fig. 9 is a schematic structural view of another embodiment of a luminal stent;
图10是管腔支架的又一实施方式的结构示意图;Fig. 10 is a schematic structural view of another embodiment of a luminal stent;
图11是又一实施例的管腔支架的结构示意图;Fig. 11 is a schematic structural view of a lumen stent in another embodiment;
图12是再一实施例的管腔支架的结构示意图;Fig. 12 is a schematic structural view of a lumen stent in another embodiment;
图13为一实施例的管腔支架中,束缚通道对应波形环状物束缚的局部结构示意图。Fig. 13 is a schematic diagram of the partial structure of the binding channel corresponding to the confinement of the wave-shaped ring in the endoluminal stent of an embodiment.
具体实施方式Detailed ways
为使本发明的上述目的、特征和优点能够更加明显易懂,下面结合附图对本发明的具体实施方式做详细的说明。在下面的描述中阐述了很多具体细节以便于充分理解本发明。但是本发明能够以很多不同于在此描述的其它方式来实施,本领域技术人员可以在不违背本发明内涵的情况下做类似改进,因此本发明不受下面公开的具体实施的限制。In order to make the above objects, features and advantages of the present invention more comprehensible, specific implementations of the present invention will be described in detail below in conjunction with the accompanying drawings. In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present invention. However, the present invention can be implemented in many other ways different from those described here, and those skilled in the art can make similar improvements without departing from the connotation of the present invention, so the present invention is not limited by the specific implementations disclosed below.
需要说明的是,当元件被称为“固定于”或“设置于”另一个元件,它可以直接在另一个元件上或者也可以存在居中的元件。当一个元件被认为是“连接”另一个元件,它可以是直接连接到另一个元件或者可能同时存在居中元件。本文所使用的术语“垂直的”、“水平的”、“左”、“右”以及类似的表述只是为了说明目的,并不表示是唯一的实施方式。It should be noted that when an element is referred to as being “fixed on” or “disposed on” another element, it may be directly on the other element or there may be an intervening element. When an element is referred to as being "connected to" another element, it can be directly connected to the other element or intervening elements may also be present. The terms "vertical," "horizontal," "left," "right," and similar expressions are used herein for purposes of illustration only and are not intended to represent the only embodiments.
除非另有定义,本文所使用的所有技术和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同。本文中在本发明的说明书中所使用的术语只是为了描述具体的实施方式的目的,不是旨在于限制本发明。本文所使用的术语“及/或”包括一个或多个相关的所列项目的任意的和所有的组合。Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the technical field of the invention. The terminology used herein in the description of the present invention is only for the purpose of describing specific embodiments, and is not intended to limit the present invention. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed items.
需要说明的是,定义管腔支架在释放后距心脏近的一端为近端,距心脏远的一端为远端。It should be noted that the end of the endoluminal stent that is closer to the heart after release is defined as the proximal end, and the end farther from the heart is defined as the distal end.
参阅图1所示,本申请实施例之一提供了一种管腔支架,包括管状主体 10以及连接在管状主体10上、对管状主体10进行径向约束的半释放装置20。Referring to FIG. 1 , one embodiment of the present application provides a lumen stent, which includes a tubular body 10 and a semi-releasing device 20 connected to the tubular body 10 for constraining the tubular body 10 radially.
半释放装置20包括至少2根限位杆21以及设于管状主体10上的束缚线22。其中,束缚线22具有锁定部22a,至少2根限位杆21沿管状主体10的周向彼此间隔地限位于管状主体10,也就是说,这些限位杆21在沿管状主体10的周向上,一方面彼此之间间隔设置,同时,各限位杆21被限位于管状主体10,继而不能沿管状主体10的周向相对管状主体10移动,以便于限位杆21于锁定部22a相连接时,可以通过束缚线22对管状主体10进行周向束缚,具体地,当限位杆21与锁定部22a相连接时,锁定部22a沿限位杆21的径向限位于限位杆21并使得束缚线22对管状主体10周向束缚。需要特别说明的是,限位杆21与锁定部22a之间为可分离连接,这样,在限位杆21与锁定部22a分离时,便可以解除该限位杆21通过锁定部22a对束缚线22进行牵引而对管状主体10的束缚力,使得管状主体10的部分被释放。且由于半释放装置20包括至少2根限位杆21,从而在先后分别释放不同的限位杆21时,可以实现对管状主体10的被束缚位置进行分步释放,以提高释放操作的可控性以及释放定位精度。与现有技术相比,在对管状主体10的被束缚位置进行分步释放时,可以先对至少2根限位杆21中的一根释放,从而解除束缚线22对管状主体10的一部分束缚,从而使得管状主体10的尺寸更加接近锚定于血管内的尺寸,从而在对管状主体进行定位时更加精准。The half release device 20 includes at least two limiting rods 21 and a binding wire 22 arranged on the tubular body 10 . Wherein, the binding wire 22 has a locking portion 22a, and at least two limiting rods 21 are limited to the tubular body 10 along the circumferential direction of the tubular body 10 at intervals. On the one hand, they are spaced apart from each other, and at the same time, each limiting rod 21 is limited to the tubular main body 10, and then cannot move relative to the tubular main body 10 along the circumferential direction of the tubular main body 10, so that the limiting rods 21 are connected to the locking portion 22a At this time, the tubular main body 10 can be constrained circumferentially by the binding wire 22, specifically, when the limiting rod 21 is connected to the locking portion 22a, the locking portion 22a is limited to the limiting rod 21 along the radial direction of the limiting rod 21 and The binding wire 22 is made to bind the tubular body 10 circumferentially. It should be noted that the limiting rod 21 and the locking portion 22a are detachably connected, so that when the limiting rod 21 is separated from the locking portion 22a, the binding of the limiting rod 21 to the binding wire by the locking portion 22a can be released. 22 exerts traction on the binding force on the tubular body 10, so that part of the tubular body 10 is released. And because the half release device 20 includes at least two limit rods 21, when releasing different limit rods 21 successively, the restrained position of the tubular body 10 can be released step by step, so as to improve the controllability of the release operation. performance and release positioning accuracy. Compared with the prior art, when the restrained position of the tubular body 10 is released step by step, one of the at least two limit rods 21 can be released first, thereby releasing the restraint of a part of the tubular body 10 by the restraining wire 22 , so that the size of the tubular body 10 is closer to the size anchored in the blood vessel, so that the positioning of the tubular body is more precise.
束缚线22与管状主体10相连接,并对折形成第一股线束221和第二股线束222,束缚线22对折位置形成锁定部22a,至少2根限位杆21穿设于第一股线束221和第二股线束222之间。The binding wire 22 is connected with the tubular main body 10, and folded in half to form a first wire bundle 221 and a second wire bundle 222, the folding position of the binding wire 22 forms a locking portion 22a, and at least two limit rods 21 are passed through the first wire bundle 221 and the second wire harness 222.
以图1示出的半释放装置20包括3根限位杆21为例,为便于描述,将该3根限位杆21分别称为“第一限位杆21'”、“第二限位杆21””和“第三限位杆21”'”,第一限位杆21'、第二限位杆21”和第三限位杆21”'分别沿管状主体10的周向彼此间隔地限位于管状主体10。第一限位杆21'、第二限位杆21”和第三限位杆21”'均穿设在第一股线束221和第二股线束222之间,从而释放靠近锁定部22a的第一限位杆21'时,管状主体10的部分失去束缚线22的束缚而扩张,即管状主体10的部分被释放,直到锁定部22a与第二限位杆21”相配合(参阅图2所示),此时,束缚线22在第二限位杆21”的约束下而被管状主体10保持在舒张状态,同时,管状主体10在束缚线22的约束下不再继续扩张,即管状主体10仍处于局部被周向束缚的状态。由于第一限位杆21'与锁定部22a分离后,管状主体10的一部分结构失去束缚线22的周向束缚而展开,从而该被展开的部分具有良好的稳定性。相应地,在释放与锁定部22a相配合的第三限位杆21”'时,管状主体10将扩张至使得锁定部22a与第三限位杆21”'相配合,此时,束缚线22在第三 限位杆21”'的约束下而被管状主体10保持在舒张状态,同时,管状主体10在束缚线22的约束下不再继续扩张,即管状主体10仍处于局部被周向束缚的状态。Taking the half-release device 20 shown in FIG. 1 as an example including three limit rods 21, for the convenience of description, the three limit rods 21 are respectively referred to as "the first limit rod 21'" and "the second limit rod 21'". The rod 21"" and the "third limiting rod 21"'", the first limiting rod 21', the second limiting rod 21" and the third limiting rod 21"' are spaced apart from each other along the circumferential direction of the tubular body 10 The ground is limited to the tubular body 10 . The first limit rod 21', the second limit rod 21" and the third limit rod 21"' are all passed between the first strand bundle 221 and the second strand bundle 222, so as to release the first strand close to the locking part 22a. When a stop bar 21', the part of the tubular main body 10 loses the restraint of the binding line 22 and expands, that is, the part of the tubular main body 10 is released until the locking part 22a is matched with the second stop bar 21" (see Fig. 2 shown), at this time, the binding wire 22 is kept in a relaxed state by the tubular body 10 under the constraint of the second limit rod 21", and at the same time, the tubular body 10 no longer continues to expand under the constraint of the binding line 22, that is, the tubular body 10 is still in a partially circumscribed state. After the first limiting rod 21 ′ is separated from the locking portion 22a, a part of the tubular body 10 loses the circumferential restraint of the binding wire 22 and unfolds, so that the unfolded part has good stability. Correspondingly, when the third limiting rod 21"' matched with the locking part 22a is released, the tubular body 10 will expand to make the locking part 22a cooperate with the third limiting rod 21"'. At this time, the binding wire 22 Under the constraint of the third limit rod 21"', the tubular body 10 is kept in a relaxed state. At the same time, the tubular body 10 no longer continues to expand under the constraint of the binding line 22, that is, the tubular body 10 is still partially bound in the circumferential direction. status.
上述实施方式中,通过逐步地解除与锁定部22a相配合的限位杆2122(如第一限位杆21'、第二限位杆21”和第三限位杆21”'),依次解除第一限位杆21'、第二限位杆21”和第三限位杆21”'与锁定部22a的配合后,管状主体10将完全展开,完成释放。本发明的管腔支架可以满足对管状主体10的局部进行分步释放的需要,从而使得释放操作的可控性良好,这样在移动管状主体10至需要植入的位置时,可以提高定位精度。In the above-mentioned embodiment, by gradually releasing the limit rods 2122 (such as the first limit rod 21', the second limit rod 21" and the third limit rod 21"') that cooperate with the locking part 22a, the After the first limiting rod 21 ′, the second limiting rod 21 ″ and the third limiting rod 21 ″’ cooperate with the locking portion 22 a, the tubular body 10 will be fully unfolded and released. The endoluminal stent of the present invention can meet the requirement of step-by-step release of the tubular body 10, so that the controllability of the release operation is good, and the positioning accuracy can be improved when the tubular body 10 is moved to the position to be implanted.
此外,在一些实施方式中,结合图3所示,分支窗口105设置第一限位杆21'和第二限位杆21”之间的部分。由于该部分可以通过第一限位杆21'与锁定部22a的配合而得到释放,即不再受束缚线22的束缚而处于舒张状态,具有良好的稳定性。确切的说,在第一限位杆21'与锁定部22a分离后,第二限位杆21”能够继续将束缚线22保持在对管状主体10进行局部周向束缚的状态,以便后续调整管状主体10位置,对分支窗口105进行定位,从而提高分支窗口105的定位准确性。In addition, in some embodiments, as shown in FIG. 3 , the branch window 105 is provided with a part between the first limit rod 21 ′ and the second limit rod 21 ″. Since this part can pass through the first limit rod 21 ′ The cooperation with the locking part 22a is released, that is, it is no longer bound by the binding wire 22 and is in a relaxed state, which has good stability. To be exact, after the first limiting rod 21' is separated from the locking part 22a, the second The two limit rods 21" can continue to keep the binding wire 22 in the state of partially circumferentially restraining the tubular body 10, so as to adjust the position of the tubular body 10 and position the branch window 105, thereby improving the positioning accuracy of the branch window 105 .
需要说明的是,在其他实施方式中,需要定位的部件不局限于分支窗口105,也可以是分支或龙骨等对定位要求较高的其他部件,这些部件设置管状主体10对应两个限位杆21之间的位置,就可以通过前述的分步释放的方式,来提升释放位置准确性。It should be noted that, in other embodiments, the components that need to be positioned are not limited to the branch window 105, and may also be other components that require high positioning, such as branches or keels, and these components are provided with the tubular body 10 corresponding to the two limit rods 21, you can improve the accuracy of the release position through the aforementioned step-by-step release method.
在至少2根限位杆21沿管状主体10的周向彼此间隔地限位于管状主体10的实施方式中,对于限位杆21相对管状主体10的周向限位方式,可以是利用定位结构,也可以是利用前述提到的束缚线22本身将限位杆21相对管状主体10周向限位于第一股线束221和第二股线束222与管状主体10的连接位置处。In the embodiment where at least two limiting rods 21 are spaced apart from each other along the circumferential direction of the tubular body 10 and are limited to the tubular body 10 , for the circumferential limiting of the limiting rods 21 relative to the tubular body 10 , a positioning structure may be used, It is also possible to use the above-mentioned binding wire 22 itself to restrict the limiting rod 21 relative to the tubular body 10 at the connection position of the first strand bundle 221 and the second strand bundle 222 with the tubular body 10 .
例如,结合图3和图4所示,管状主体10上固定连接有锁扣104,锁扣104用于供至少2根限位杆21中的任意一根穿过。For example, as shown in FIG. 3 and FIG. 4 , a locking buckle 104 is fixedly connected to the tubular body 10 , and the locking buckle 104 is used for allowing any one of at least two limiting rods 21 to pass through.
管状主体10上固定连接有多个锁扣104,锁扣104的数量与限位杆21的数量相等,多个锁扣104分别对应地将限位杆21沿管状主体10的周向限位于管状主体10。The tubular body 10 is fixedly connected with a plurality of locks 104, the number of the locks 104 is equal to the number of the limit rods 21, and the plurality of locks 104 correspondingly limit the limit rods 21 to the tubular body 10 along the circumferential direction of the tubular body 10. Subject 10.
在一些实施方式中,管状主体10上固定连接有多个锁扣104,至少2根限位杆21分别沿其自身轴向可活动地穿设于多个锁扣104。In some embodiments, a plurality of locking buckles 104 are fixedly connected to the tubular body 10 , and at least two limiting rods 21 are respectively movably threaded through the plurality of locking buckles 104 along their own axial directions.
在另一些实施方式中,至少2根限位杆21中的一根沿与束缚线22管状主体10沿管状主体10周侧的延伸方向的相反方向上,被束缚线22束缚于束缚线22与管状主体10的连接位置,多个锁扣104对应地将其他的限位杆21 沿管状主体10的周向限位于管状主体10。In some other embodiments, one of the at least two limiting rods 21 is bound by the binding line 22 between the binding line 22 and the At the connection position of the tubular body 10 , a plurality of locking buckles 104 correspondingly limit the other limiting rods 21 to the tubular body 10 along the circumferential direction of the tubular body 10 .
以图3和图4所示的管腔支架为例,限位杆21的数量为2根,分别为第一限位杆21'和第二限位杆21”,第一限位杆21'沿与束缚线22管状主体10沿管状主体10周侧的延伸方向的相反方向上,被束缚线22束缚于束缚线22的第一股线束221及第二股线束222与管状主体10的连接位置,锁扣104对应地将第二限位杆21”沿管状主体10的周向限位于管状主体10。Taking the lumen stent shown in Figure 3 and Figure 4 as an example, the number of limit rods 21 is two, which are respectively the first limit rod 21' and the second limit rod 21", and the first limit rod 21' In the direction opposite to the extension direction of the tubular main body 10 along the peripheral side of the tubular main body 10 with the binding line 22 , the connection position of the first strand bundle 221 and the second strand bundle 222 bound by the binding wire 22 to the tubular main body 10 , the locking buckle 104 correspondingly constrains the second limiting rod 21 ″ on the tubular main body 10 along the circumferential direction of the tubular main body 10 .
结合图5和图6所示,束缚线22具有固定部22b以及至少2个锁定部22a,固定部22b与管状主体10固定连接,至少2根限位杆21分别对应地穿设于至少2个锁定部22a,从而解除相应的限位杆21与锁定部22a的配合后,束缚线22对应地解除对管状主体10的局部束缚,从而先后依次将不同位置的限位杆21抽离,可以实现对管状主体10进行分步释放的效果。5 and 6, the binding wire 22 has a fixed part 22b and at least two locking parts 22a, the fixed part 22b is fixedly connected with the tubular main body 10, and at least two limit rods 21 are correspondingly installed in at least two locking part 22a, so that after releasing the cooperation between the corresponding stop rod 21 and the lock part 22a, the binding wire 22 correspondingly releases the local restraint on the tubular main body 10, so that the stop rods 21 at different positions are successively pulled away, which can realize The effect of the stepwise release of the tubular body 10 .
需要说明的是,在束缚线22具有至少2个锁定部22a的实施方式中,这些锁定部22a相对固定部22b可以是位于同一侧,也可以是位于不同侧。例如,以束缚线22包括2个锁定部22a为例,如图5所示,2个锁定部22a彼此间隔地位于固定部22b的同一侧,或者,如图6所示,2个锁定部22a彼此间隔地位于固定部22b的不同侧。It should be noted that, in the embodiment where the binding wire 22 has at least two locking portions 22a, these locking portions 22a may be located on the same side or different sides relative to the fixing portion 22b. For example, taking the binding wire 22 including two locking portions 22a as an example, as shown in FIG. They are located on different sides of the fixing portion 22b at intervals from each other.
在一些实施方式中,结合图7所示,束缚线22具有固定部22b以及线环22c,固定部22b与管状主体10固定连接,线环22c的远离固定部22b的端部位置形成锁定部22a,2根或2根以上的限位杆21穿设于线环22c,从而将与锁定部22a相配合的限位杆21抽离后,管状主体10扩张而使得线环22c的锁定部22a与相邻的限位杆21相配合,依次类推,依次抽离与锁定部22a相配合的限位杆21,便可以实现分步释放管状主体10,从而提高释放操作的可控性,以及释放精准性。In some embodiments, as shown in FIG. 7 , the binding wire 22 has a fixed portion 22b and a wire loop 22c, the fixed portion 22b is fixedly connected to the tubular body 10, and the end position of the wire loop 22c away from the fixed portion 22b forms a locking portion 22a Two or more limit rods 21 are passed through the wire loop 22c, so that after the limit rod 21 matched with the locking part 22a is pulled out, the tubular main body 10 expands so that the lock part 22a of the wire ring 22c and the Adjacent limit rods 21 are matched, and so on, and the limit rods 21 matched with the locking portion 22a are sequentially pulled out, so that the tubular body 10 can be released step by step, thereby improving the controllability of the release operation and the release accuracy. sex.
进一步地,结合图8和图9所示,束缚线22具有至少2个线环22c,至少2个线环22c彼此间隔地位于固定部22b的不同侧(参阅图8所示)或同一侧(参阅图9所示)。Further, as shown in FIG. 8 and FIG. 9, the binding wire 22 has at least 2 wire loops 22c, and at least 2 wire loops 22c are located at different sides of the fixing part 22b (see FIG. 8 ) or on the same side ( See Figure 9).
结合图10所示,管状主体10上设置有束缚通道24,束缚通道24对应的圆心角小于360°,束缚通道24对应限位杆21的位置形成有开口24a,开口24a与束缚通道24的内腔相连通,束缚线22穿设于束缚通道24内,锁定部22a用于在开口24a处与对应的限位杆21连接。As shown in FIG. 10 , the tubular body 10 is provided with a binding channel 24 , the central angle corresponding to the binding channel 24 is less than 360°, and the position of the binding channel 24 corresponding to the limit rod 21 is formed with an opening 24 a , and the opening 24 a is connected to the inside of the binding channel 24 . The cavities are connected, the restraint wire 22 passes through the restraint passage 24, and the locking portion 22a is used to connect with the corresponding limit rod 21 at the opening 24a.
需要说明的是,束缚通道24的结构具有多种可能,例如,如图10和图11所示,管腔支架包括可隔绝血流的覆膜102,覆膜102的外表面设置有覆盖物103,束缚通道24形成于覆盖物103与覆膜102之间;或者,如图1至图3所示,管状主体10上设置有多个限位环扣223,束缚通道24由多个限位环扣223形成,束缚线22从限位环扣223中穿设。It should be noted that the structure of the binding channel 24 has many possibilities. For example, as shown in FIG. 10 and FIG. , the binding channel 24 is formed between the cover 103 and the covering film 102; or, as shown in FIGS. A buckle 223 is formed, and the binding wire 22 passes through the buckle 223 of the limiting ring.
结合图12和图13所示,管状主体10包括波形环状物101,波形环状物101采用具有良好生物相容性的材料制成,如镍钛、不锈钢等材料。在一些实施方式中,多圈波形环状物101沿管状主体10的轴向从近端到远端依次排布,优选为平行间隔排布。As shown in FIG. 12 and FIG. 13 , the tubular body 10 includes a wave-shaped ring 101 , and the wave-shaped ring 101 is made of materials with good biocompatibility, such as nickel-titanium, stainless steel and other materials. In some embodiments, the multi-turn wave-shaped rings 101 are arranged sequentially along the axial direction of the tubular body 10 from the proximal end to the distal end, preferably in parallel and at intervals.
波形环状物101包括多个波峰101a、多个波谷101b及多个分别连接相邻波峰101a与波谷101b的连接杆101c。波形环状物101为闭合圆柱状结构,多圈波形环状物101间可以具有相同或相似的波形形状,可以理解的是,本实施例并不限定波形环状物101的具体结构,波形环状物101的波形可以根据需要设置,同时每圈波形环状物101中的波形个数以及波形高度均可根据需要设置。The wave-shaped ring 101 includes a plurality of crests 101a, a plurality of troughs 101b, and a plurality of connecting rods 101c respectively connecting adjacent crests 101a and troughs 101b. The wave-shaped ring 101 is a closed cylindrical structure, and the multi-turn wave-shaped rings 101 may have the same or similar wave shapes. It can be understood that this embodiment does not limit the specific structure of the wave-shaped ring 101. The wave-shaped ring The waveform of the shape 101 can be set as required, and the number of waveforms and the height of the waveform in each wave ring 101 can be set as required.
多圈波形环状物101上连接有覆膜102,覆膜102采用具有良好生物相容性的高分子材料制成,如PTFE(Poly tetra fluoroethylene,聚四氟乙烯)、FEP(Fluorinated ethylene propylen,全氟乙烯丙烯共聚物)和PET(Polyethylene terephthalate,聚对苯二甲酸乙二醇酯)等。The multi-circle corrugated ring 101 is connected with a coating 102, and the coating 102 is made of a polymer material with good biocompatibility, such as PTFE (Poly tetrafluoroethylene, polytetrafluoroethylene), FEP (Fluorinated ethylene propylene, Perfluoroethylene propylene copolymer) and PET (Polyethylene terephthalate, polyethylene terephthalate), etc.
在一些实施方式中,继续参阅图12和图13所示,在波形环状物101所在的轴向区间内,管状主体10上具有间隔设置的至少2个束缚通道24与波形环状物101相对应,至少2个束缚通道24内的束缚线22分别用于对波形环状物101的中位线圈的一侧及另一侧施加径向约束力。其中,中位线圈是指波形环状物101中各连接杆101c的中点沿管状主体10的周侧依次连接形成的环形线圈。通过这种结构设置,波形环状物101的波峰101a和波谷101b被均匀束缚,从而避免波峰101a和波谷101b受力不均而导致偏向一侧,继而引起波峰101a或波谷101b翘起而与血管壁锚定或接触摩擦力较大,影响管腔支架的轴向和周向位置的调整。In some embodiments, as shown in FIG. 12 and FIG. 13 , in the axial section where the wave-shaped ring 101 is located, there are at least two confinement channels 24 arranged at intervals on the tubular body 10 corresponding to the wave-shaped ring 101 . Correspondingly, the binding wires 22 in at least two binding channels 24 are respectively used to apply radial binding force to one side and the other side of the neutral coil of the wave-shaped ring 101 . Wherein, the neutral coil refers to the ring coil formed by sequentially connecting the midpoints of the connecting rods 101c in the wave-shaped ring 101 along the peripheral side of the tubular body 10 . Through this structural arrangement, the crests 101a and troughs 101b of the wave-shaped ring 101 are uniformly restrained, thereby avoiding the uneven force on the crests 101a and troughs 101b and causing them to be biased to one side, which in turn will cause the crests 101a or troughs 101b to warp and align with the blood vessels. Wall anchoring or contact friction is relatively large, which affects the adjustment of the axial and circumferential positions of the luminal stent.
继续参阅图12和图13所示,波形环状物101还包括沿其轴向间隔相对、并环绕其周侧的第一区域A1和第二区域A2,第一区域A1的宽度D1为以波峰101a为起点沿轴向向波谷101b方向延伸2/5倍波高,也就是说,界定该第一区域A1的宽度D1的两条边b1、b2分别环绕在波形环状物101的对应波峰101a的位置,以及到波峰101a的垂直距离为2/5倍波高的位置。第二区域A2的宽度D2为以波谷101b为起点沿轴向向波峰101a方向延伸2/5倍波高,也就是说,界定该第二区域A2的宽度D2的两条边b3、b4分别环绕在波形环状物101的对应波谷101b的位置,以及到波谷101b的垂直距离为2/5倍波高的位置。需要注意的是,波高是指波峰101a沿波形环状物101的轴线方向到波谷101b的垂直距离。Continuing to refer to FIG. 12 and FIG. 13 , the wave-shaped ring 101 also includes a first area A1 and a second area A2 that are opposite to each other along its axial direction and surround its circumference. The width D1 of the first area A1 is represented by the peak 101a is the starting point and extends axially toward the trough 101b for 2/5 times the wave height, that is to say, the two sides b1 and b2 defining the width D1 of the first region A1 surround the corresponding peak 101a of the wave-shaped ring 101 respectively. position, and the vertical distance to the peak 101a is 2/5 times the wave height. The width D2 of the second area A2 is 2/5 times the wave height starting from the wave trough 101b and extending axially toward the wave peak 101a, that is to say, the two sides b3 and b4 defining the width D2 of the second area A2 surround The position of the wave-shaped ring 101 corresponds to the trough 101b, and the vertical distance to the trough 101b is 2/5 times the wave height. It should be noted that the wave height refers to the vertical distance from the wave crest 101 a to the wave trough 101 b along the axis direction of the wave-shaped ring 101 .
至少2个束缚通道24中的至少1个位于第一区域A1内,至少2个束缚通道24中的至少1个位于第二区域A2内。从而位于束缚通道24中的束缚线 22分别对应地对波形环状物101的对应第一区域A1和第二区域A2的位置进行束缚,以使得波形环状物101的波峰101a和波谷101b位置受力均匀,以提高管状主体10的稳定性,避免了波峰101a或波谷101b翘起。At least one of the at least two confinement channels 24 is located in the first area A1, and at least one of the at least two confinement channels 24 is located in the second area A2. Therefore, the binding wires 22 located in the binding channel 24 respectively constrain the positions corresponding to the first area A1 and the second area A2 of the wave-shaped ring 101, so that the positions of the peaks 101a and the valleys 101b of the wave-shaped ring 101 are restricted. The force is uniform to improve the stability of the tubular body 10 and avoid the crests 101a or troughs 101b from warping.
以上所述实施例的各技术特征可以进行任意的组合,为使描述简洁,未对上述实施例中的各个技术特征所有可能的组合都进行描述,然而,只要这些技术特征的组合不存在矛盾,都应当认为是本说明书记载的范围。The technical features of the above-mentioned embodiments can be combined arbitrarily. To make the description concise, all possible combinations of the technical features in the above-mentioned embodiments are not described. However, as long as there is no contradiction in the combination of these technical features, should be considered as within the scope of this specification.
以上所述实施例仅表达了本发明的几种实施方式,其描述较为具体和详细,但并不能因此而理解为对发明专利范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干变形和改进,这些都属于本发明的保护范围。因此,本发明专利的保护范围应以所附权利要求为准。The above-mentioned embodiments only express several implementation modes of the present invention, and the descriptions thereof are relatively specific and detailed, but should not be construed as limiting the patent scope of the invention. It should be noted that those skilled in the art can make several modifications and improvements without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent for the present invention should be based on the appended claims.

Claims (20)

  1. 一种管腔支架,包括管状主体以及连接在所述管状主体上的半释放装置,其特征在于,所述半释放装置包括设于所述管状主体上的束缚线以及至少2根限位杆,所述束缚线具有锁定部,所述至少2根限位杆沿所述管状主体的周向彼此间隔地限位于所述管状主体,并用于与所述锁定部可分离连接,其中,当所述限位杆与所述锁定部相连接时,所述锁定部沿所述限位杆的径向限位于所述限位杆并使得所述束缚线对所述管状主体周向束缚。A lumen stent, comprising a tubular body and a semi-releasing device connected to the tubular body, characterized in that the semi-releasing device comprises a binding wire and at least two limit rods arranged on the tubular body, The binding wire has a locking part, and the at least two limiting rods are limited to the tubular body at intervals along the circumferential direction of the tubular body, and are used for detachable connection with the locking part, wherein, when the When the limiting rod is connected to the locking part, the locking part is limited to the limiting rod along the radial direction of the limiting rod and makes the binding wire bind the tubular main body in a circumferential direction.
  2. 根据权利要求1所述的管腔支架,其特征在于,所述束缚线与所述管状主体相连接,并对折形成第一股线束和第二股线束,所述束缚线对折位置形成所述锁定部,所述至少2根限位杆穿设于所述第一股线束和所述第二股线束之间。The endoluminal stent according to claim 1, wherein the binding wire is connected to the tubular body and folded in half to form a first strand bundle and a second strand bundle, and the folding position of the binding wire forms the locking part, the at least 2 limit rods are passed between the first wire bundle and the second wire bundle.
  3. 根据权利要求2所述的管腔支架,其特征在于,在沿与所述束缚线环绕所述管状主体的方向的相反方向上,所述至少2根所述限位杆中的一根被所述束缚线束缚于所述束缚线与所述管状主体的连接位置。The endoluminal stent according to claim 2, wherein one of the at least two limiting rods is held in a direction opposite to the direction in which the binding wire encircles the tubular body. The tethering wire is bound at a connection location of the tethering wire to the tubular body.
  4. 根据权利要求1所述的管腔支架,其特征在于,所述束缚线具有固定部以及至少2个所述锁定部,所述固定部与所述管状主体固定连接,所述至少2根限位杆分别对应地穿设于所述至少2个锁定部。The endoluminal stent according to claim 1, wherein the binding wire has a fixing part and at least two locking parts, the fixing part is fixedly connected with the tubular body, and the at least two limiting wires The rods are correspondingly passed through the at least two locking parts.
  5. 根据权利要求4所述的管腔支架,其特征在于,所述至少2个锁定部彼此间隔地位于所述固定部的同一侧。The endoluminal stent according to claim 4, wherein the at least two locking parts are located on the same side of the fixing part at intervals from each other.
  6. 根据权利要求4所述的管腔支架,其特征在于,所述至少2个锁定部彼此间隔地位于所述固定部的不同侧。The endoluminal stent according to claim 4, wherein the at least two locking parts are located on different sides of the fixing part at intervals from each other.
  7. 根据权利要求1所述的管腔支架,其特征在于,所述束缚线具有固定部以及线环,所述固定部与所述管状主体固定连接,所述线环的远离所述固定部的端部位置形成所述锁定部,2根或2根以上的所述限位杆穿设于所述线环。The endoluminal stent according to claim 1, wherein the binding wire has a fixing part and a wire loop, the fixing part is fixedly connected to the tubular body, and the end of the wire ring far away from the fixing part The locking part is formed at the upper part, and two or more limiting rods are passed through the wire loop.
  8. 根据权利要求7所述的管腔支架,其特征在于,所述束缚线具有至少2个所述线环,所述至少2个所述线环彼此间隔地位于所述固定部的同一侧。The endoluminal stent according to claim 7, wherein the binding wire has at least two wire loops, and the at least two wire loops are located on the same side of the fixing part at intervals from each other.
  9. 根据权利要求7所述的管腔支架,其特征在于,所述束缚线具有至少2个所述线环,所述至少2个所述线环彼此间隔地位于所述固定部的不同侧。The endoluminal stent according to claim 7, wherein the binding wire has at least two wire loops, and the at least two wire loops are located on different sides of the fixing part at intervals.
  10. 根据权利要求1-9任一项所述的管腔支架,其特征在于,所述管状主体上固定连接有多个锁扣,所述至少2根限位杆分别沿其自身轴向可活动地穿设于多个所述锁扣。The endoluminal stent according to any one of claims 1-9, wherein a plurality of locking buckles are fixedly connected to the tubular body, and the at least two limit rods are respectively movable along their own axial directions. Piercing through a plurality of said lock buckles.
  11. 根据权利要求1-9任一项所述的管腔支架,其特征在于,所述管状主体上固定连接有多个锁扣,所述锁扣的数量与所述限位杆的数量相等,多个所述锁扣分别对应地将所述限位杆沿所述管状主体的周向限位于所述管状 主体。The endoluminal stent according to any one of claims 1-9, wherein the tubular body is fixedly connected with a plurality of locking buckles, the number of the locking buckles is equal to the number of the limit rods, more Each of the locking buckles correspondingly restricts the limiting rod to the tubular main body along the circumferential direction of the tubular main body.
  12. 根据权利要求1所述的管腔支架,其特征在于,所述管状主体上设置有束缚通道,所述束缚通道对应的圆心角小于360°,所述束缚通道对应所述限位杆的位置形成有开口,所述开口与所述束缚通道的内腔相连通,所述束缚线穿设于所述束缚通道内,所述锁定部用于在所述开口处与对应的所述限位杆连接。The endoluminal stent according to claim 1, wherein a binding channel is provided on the tubular body, the central angle corresponding to the binding channel is less than 360°, and the binding channel is formed corresponding to the position of the limiting rod There is an opening, the opening communicates with the inner cavity of the restraint channel, the restraint wire is passed through the restraint channel, and the locking part is used to connect with the corresponding limit rod at the opening .
  13. 根据权利要求12所述的管腔支架,其特征在于,所述管状主体包括波形环状物,在所述波形环状物所在的轴向区间内,所述管状主体上具有间隔设置的至少2个所述束缚通道与所述波形环状物相对应,所述至少2个束缚通道内的束缚线分别用于对所述波形环状物的中位线圈的一侧及另一侧施加径向约束力。The endoluminal stent according to claim 12, wherein the tubular body comprises a wave-shaped ring, and in the axial section where the wave-shaped ring is located, the tubular body has at least 2 holes arranged at intervals. One of the binding channels corresponds to the wave-shaped ring, and the binding wires in the at least two binding channels are respectively used to apply a radial direction to one side and the other side of the median coil of the wave-shaped ring. binding.
  14. 根据权利要求13所述的管腔支架,其特征在于,所述波形环状物包括多个波峰、多个波谷及多个分别连接相邻的所述波峰与所述波谷的连接杆,所述波形环状物还包括沿其轴向间隔相对的、并环绕其周侧的第一区域和第二区域,所述第一区域的宽度为以所述波峰为起点沿轴向向所述波谷方向延伸2/5倍波高,所述第二区域的宽度为以所述波谷为起点沿轴向向所述波峰方向延伸2/5倍波高,所述至少2个束缚通道中的至少1个位于所述第一区域内,所述至少2个束缚通道中的至少1个位于所述第二区域内。The endoluminal stent according to claim 13, wherein the wave-shaped ring comprises a plurality of crests, a plurality of troughs, and a plurality of connecting rods respectively connecting the adjacent crests and the troughs, the The wave-shaped ring also includes a first region and a second region that are spaced apart from each other along its axial direction and surround its peripheral side. The width of the first region is from the peak to the trough in the axial direction Extending 2/5 times the wave height, the width of the second region is to extend 2/5 times the wave height from the trough in the axial direction to the wave peak direction, at least one of the at least 2 confinement channels is located at the In the first area, at least one of the at least two confinement channels is located in the second area.
  15. 根据权利要求13或14所述的管腔支架,其特征在于,所述管状主体包括多圈所述波形环状物,多圈所述波形环状物沿所述管状主体的轴向从近端到远端依次排布。The endoluminal stent according to claim 13 or 14, wherein the tubular body comprises multiple turns of the wave-shaped ring, and the wave-shaped ring of multiple turns extends from the proximal end along the axial direction of the tubular body Arranged sequentially to the far end.
  16. 根据权利要求15所述的管腔支架,其特征在于,多圈所述波形环状物平行间隔排布。The endoluminal stent according to claim 15, wherein multiple turns of the wave-shaped rings are arranged in parallel and at intervals.
  17. 根据权利要求15所述的管腔支架,其特征在于,多圈所述波形环状物上连接有覆膜,所述覆膜的材料为聚四氟乙烯、全氟乙烯丙烯共聚物或聚对苯二甲酸乙二醇酯。The endoluminal stent according to claim 15, characterized in that, multiple turns of the wave-shaped ring are connected with a covering film, and the material of the covering film is polytetrafluoroethylene, perfluoroethylene propylene copolymer or polyparaffin. Ethylene glycol phthalate.
  18. 根据权利要求15所述的管腔支架,其特征在于,多圈所述波形环状物上连接有覆膜,所述覆膜的外表面设置有覆盖物,所述束缚通道形成于所述覆盖物与所述覆膜之间。The endoluminal stent according to claim 15, characterized in that, multiple turns of the wave-shaped ring are connected with a coating, the outer surface of the coating is provided with a covering, and the binding channel is formed on the covering. between the object and the covering film.
  19. 根据权利要求12所述的管腔支架,其特征在于,所述管状主体上设置有多个限位环扣,多个所述限位环扣形成所述束缚通道。The endoluminal stent according to claim 12, wherein the tubular body is provided with a plurality of limiting rings, and the plurality of limiting rings form the binding channel.
  20. 根据权利要求1所述的管腔支架,其特征在于,包括分支窗口,所述分支窗口设置于所述管状主体的对应2根所述限位杆之间的部分。The endoluminal stent according to claim 1, characterized in that it comprises a branch window, and the branch window is arranged at a part of the tubular body between the corresponding two limiting rods.
PCT/CN2022/113477 2021-08-24 2022-08-19 Luminal stent WO2023025045A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202110973223.6A CN115869105A (en) 2021-08-24 2021-08-24 Lumen stent
CN202110973223.6 2021-08-24

Publications (1)

Publication Number Publication Date
WO2023025045A1 true WO2023025045A1 (en) 2023-03-02

Family

ID=85322513

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/113477 WO2023025045A1 (en) 2021-08-24 2022-08-19 Luminal stent

Country Status (2)

Country Link
CN (1) CN115869105A (en)
WO (1) WO2023025045A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080294234A1 (en) * 2007-05-11 2008-11-27 William A. Cook Australia Pty. Ltd. Stent grafts for the thoracic aorta
US20160296352A1 (en) * 2015-04-13 2016-10-13 Cook Medical Technologies Llc Axial lock and release stent deployment system
CN107405206A (en) * 2015-01-14 2017-11-28 库克医学技术有限责任公司 Suture wire rack mount deployment system
CN110448393A (en) * 2018-12-18 2019-11-15 深圳市先健畅通医疗有限公司 Intraluminal stent
CN112891033A (en) * 2019-12-03 2021-06-04 深圳市先健畅通医疗有限公司 Lumen stent

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080294234A1 (en) * 2007-05-11 2008-11-27 William A. Cook Australia Pty. Ltd. Stent grafts for the thoracic aorta
CN107405206A (en) * 2015-01-14 2017-11-28 库克医学技术有限责任公司 Suture wire rack mount deployment system
US20160296352A1 (en) * 2015-04-13 2016-10-13 Cook Medical Technologies Llc Axial lock and release stent deployment system
CN110448393A (en) * 2018-12-18 2019-11-15 深圳市先健畅通医疗有限公司 Intraluminal stent
CN112891033A (en) * 2019-12-03 2021-06-04 深圳市先健畅通医疗有限公司 Lumen stent

Also Published As

Publication number Publication date
CN115869105A (en) 2023-03-31

Similar Documents

Publication Publication Date Title
US20220125610A1 (en) Evertable sheath devices, systems, and methods
JP6336619B2 (en) Biliary stent
CN105007865B (en) Stent-graft delivery system
US8262719B2 (en) Braided flange branch graft for branch vessel
EP3106108B1 (en) Tissue anchor for securing tissue layers
JP7450662B2 (en) Endoluminal prosthesis deployment devices and methods
US20130085562A1 (en) Apparatus for and method of pulling a tensile member from a medical device
CN105377184A (en) Embolic protection device
KR20130117810A (en) Apposion fiber for use in endoluminal deployment of expandable devices in tortuous anatomies
JP2011519709A (en) Tissue anchor for anchoring tissue layers
CN110448393B (en) Lumen stent
WO2018072432A1 (en) Luminal stent
US10420661B2 (en) Stents and stent deployment devices
WO2023025045A1 (en) Luminal stent
CN112891033B (en) Lumen stent
CN112891018B (en) Lumen stent
CN111407477B (en) Lumen stent
WO2022142761A1 (en) Luminal stent
CN112891017B (en) Lumen stent
CN114681120A (en) Lumen stent
US11963894B2 (en) Lumen stent and implant
CN115887059A (en) Lumen stent
CN111407475B (en) Lumen stent
CN114681117A (en) Lumen stent
CN117281570A (en) Conveying device and conveying system for conveying vascular stents

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22860391

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE